San Antonio Spurs rookie Harrison Ingram finished with a triple-double on Tuesday in the G League, leading the Austin Spurs to a win over the Memphis Hustle. Ingram produced 17 points, 13 rebounds, 10 ...

Activating a third receptor, in principle, could lead to stronger weight-loss effects or additional cardiometabolic benefits. Lilly is pushing ahead in the clinical assessment of its triple-G agonist ...

This is the same mechanism as Eli Lilly’s next-generation “triple-G” drug retatrutide, which has so far appeared to be the most effective obesity drug in development. In a small early ...

UBT251 targets GLP-1, GIP, and a third hormone, glucagon, hence the name "triple G". Rival Eli Lilly (LLY.N), opens new tab is developing a similar drug, retatrutide, that has shown to help ...

(Reuters) -Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G" weight-loss drug candidate in a deal worth up to $2 billion.

UBT251, a so-called “triple G” agonist, targets GLP-1, gastric inhibitory polypeptide (GIP) and glucagon. For comparison, Wegovy inhibits GLP-1 while Eli Lilly’s competitor Zepbound (tirzapetide) is a ...

No­vo Nordisk is not im­mune to the trend of seek­ing obe­si­ty as­sets from Chi­na-based biotechs, and the Dan­ish drug­mak­er will pay … ...

Danish drugmaker Novo Nordisk has bought global rights to China-based United Laboratories International's so-called "triple-G" weight-loss drug candidate in a deal worth up to $2 billion. Novo has ...

The candidate at the center of the deal, dubbed UBT251, is a triple agonist for glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP) and glucagon. Wegovy already inhibits GLP-1 ...

BIGBANG’s G-Dragon has snagged a ninth music show trophy ... on “Inkigayo,” meaning that the song has now achieved a “triple crown”!